Cardio Diagnostics Highlights Limitations of Traditional CHD Detection

Cardio Diagnostics Holdings (NASDAQ: CDIO) is drawing attention to a critical gap in coronary heart disease detection, noting that conventional risk assessment methods fail to identify approximately half of individuals who ultimately develop the condition. According to the company, traditional risk calculators have an average sensitivity of only 39%, meaning many patients who appear healthy based on standard metrics are at risk of preventable cardiac events such as heart attacks.

Coronary heart disease remains the leading cause of death in the United States. For decades, cardiovascular risk assessment has relied on factors such as cholesterol levels, blood pressure, smoking history, diabetes status, family history and weight. While these indicators provide useful information, Cardio Diagnostics argues they were never designed to capture the full biological picture of how heart disease develops.

The company has developed clinical tests rooted in epigenetics and genetics that examine how genes are expressed and regulated at the molecular level. By analyzing biological markers beyond traditional risk factors, these tests aim to identify CHD earlier and more accurately. Cardio Diagnostics emphasizes that much of the disease burden is preventable if high-risk individuals can be identified before symptoms appear.

“Approximately 50% of individuals with coronary heart disease do not present with traditional risk factors,” the company reports, highlighting a blind spot in current screening practices. The implication is that many patients who “look healthy” are not receiving preventive care or further diagnostic testing until after a cardiac event occurs.

The full terms of use and disclaimers are available on the InvestorBrandNetwork website. The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO.

Forward-looking statements in this article involve risks and uncertainties, as detailed in the company’s filings with the SEC, including the most recent Annual Report on Form 10-K and subsequent quarterly reports. Undue reliance should not be placed on these statements, which are based on information available as of the date hereof. The company undertakes no duty to update this information unless required by law.